BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29093158)

  • 1. Effects of Amerindian Genetic Ancestry on Clinical Variables and Therapy in Patients with Rheumatoid Arthritis.
    Sánchez E; García de la Torre I; Sacnún M; Goñi M; Berbotto G; Paira S; Musuruana JL; Graf C; Alvarellos A; Messina OD; Babini A; Strusberg I; Marcos JC; Scherbarth H; Spindler A; Quinteros A; Toloza S; Moreno JLC; Catoggio LJ; Tate G; Eimon A; Citera G; Pellet AC; Nasswetter G; Cardiel MH; Miranda P; Ballesteros F; Esquivel-Valerio JA; Maradiaga-Ceceña MA; Acevedo-Vásquez EM; García CG; Tusié-Luna T; Pons-Estel BA; Alarcón-Riquelme ME;
    J Rheumatol; 2017 Dec; 44(12):1804-1812. PubMed ID: 29093158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease modification in rheumatoid arthritis with leflunomide.
    Emery P
    Scand J Rheumatol Suppl; 1999; 112():9-14. PubMed ID: 10668522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leflunomide improves quality of life in rheumatoid arthritis.
    Scott DL
    Scand J Rheumatol Suppl; 1999; 112():23-9. PubMed ID: 10668524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
    Sharp JT; Strand V; Leung H; Hurley F; Loew-Friedrich I
    Arthritis Rheum; 2000 Mar; 43(3):495-505. PubMed ID: 10728741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid arthritis in Latin Americans enriched for Amerindian ancestry is associated with loci in chromosomes 1, 12, and 13, and the HLA class II region.
    López Herráez D; Martínez-Bueno M; Riba L; García de la Torre I; Sacnún M; Goñi M; Berbotto GA; Paira S; Musuruana JL; Graf CE; Alvarellos AJ; Messina OD; Babini AM; Strusberg I; Marcos JC; Scherbarth H; Spindler AJ; Quinteros A; Toloza SM; Moreno JL; Catoggio LJ; Tate G; Eimon A; Citera G; Catalán Pellet A; Nasswetter GG; Cardiel MH; Miranda P; Ballesteros F; Esquivel-Valerio JA; Maradiaga-Ceceña MA; Acevedo-Vásquez EM; García García C; Pons-Estel BA; Alarcón-Riquelme ME
    Arthritis Rheum; 2013 Jun; 65(6):1457-67. PubMed ID: 23460240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of early rheumatoid arthritis in a multinational inception cohort of Latin American patients: the GLADAR experience.
    Cardiel MH; Pons-Estel BA; Sacnun MP; Wojdyla D; Saurit V; Marcos JC; Pinto MR; Cordeiro de Azevedo AB; da Silveira IG; Radominski SC; Ximenes AC; Massardo L; Ballesteros F; Rojas-Villarraga A; Oñate RV; Hernandez MP; Esquivel-Valerio JA; García-De La Torre I; Khoury VJ; Millán A; Soriano ER;
    J Clin Rheumatol; 2012 Oct; 18(7):327-35. PubMed ID: 23047532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active Rheumatoid Arthritis in Central Africa: A Comparative Study Between Sudan and Sweden.
    Elshafie AI; Elkhalifa AD; Elbagir S; Aledrissy MI; Elagib EM; Nur MA; Weitoft T; Rönnelid J
    J Rheumatol; 2016 Oct; 43(10):1777-1786. PubMed ID: 27481904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leflunomide for rheumatoid arthritis.
    Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK; Furst DE
    Clin Geriatr Med; 2005 Aug; 21(3):649-69, viii. PubMed ID: 15911212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis.
    Mroczkowski PJ; Weinblatt ME; Kremer JM
    Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S66-8. PubMed ID: 10589360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.
    Verschueren P; De Cock D; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravelingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Meyfroidt S; Van der Elst K; Westhovens R
    Ann Rheum Dis; 2015 Jan; 74(1):27-34. PubMed ID: 25359382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of radiographic joint damage in rheumatoid arthritis patients in DAS28 remission using single- or combined with methotrexate non biological disease-modifying antirheumatic drug therapy in routine clinical practice.
    Katayama K; Okubo T; Sato T; Ito H; Fukai R; Baba H
    Mod Rheumatol; 2015 Jan; 25(1):50-5. PubMed ID: 24983407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
    Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
    Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of radiographic progression in rheumatoid arthritis by anti-rheumatic drugs (DMARDs)].
    Suzuki Y; Wakabayashi T; Saito E; Suwa A
    Clin Calcium; 2007 Apr; 17(4):546-52. PubMed ID: 17404484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid arthritis: an update.
    Derk CT
    Del Med J; 2005 Feb; 77(2):59-63. PubMed ID: 15887927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.
    Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
    James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
    J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis].
    Yukawa N; Mimori T
    Clin Calcium; 2009 Mar; 19(3):395-403. PubMed ID: 19252250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
    Dougados M; Emery P; Lemmel EM; Zerbini CA; Brin S; van Riel P
    Ann Rheum Dis; 2005 Jan; 64(1):44-51. PubMed ID: 15271770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.